General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis(MODEST), Esperion(MODEST), Abbott Diagnostic(MODEST), AstraZeneca(SIGNIFICANT), Roche Diagnostic(MODEST), Sanofi-Synthelabo(SIGNIFICANT), Amgen(SIGNIFICANT), Arrowhead(MODEST), Denka Seiken(SIGNIFICANT), Matinas BioPharma Inc(SIGNIFICANT), Regeneron(SIGNIFICANT), Gilead Sciences, Inc. (SIGNIFICANT), Amarin(SIGNIFICANT), Althera(MODEST), Pfizer Inc(MODEST), Genentech, Inc(MODEST), Ionis(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Novartis(SIGNIFICANT), Regeneron(SIGNIFICANT), Esperion(SIGNIFICANT), Abbott Diagnostic(SIGNIFICANT), Roche Diagnostic(SIGNIFICANT), Akcea(SIGNIFICANT), Amgen(SIGNIFICANT), Arrowhead(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), New Amsterdam(SIGNIFICANT)

View Full Disclosure